Kyntra Bio to Report First Quarter 2026 Financial Results
Go back to Kyntra Bio to Report First Quarter 2026 Financial Results| (NASDAQ: KYNB) | Delayed: 7.27 +0.29 (4.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.98 | 52 Week High | $ | |||
| Open | $6.97 | 52 Week Low | $ | |||
| Day High | $7.30 | P/E | N/A | |||
| Day Low | $6.97 | EPS | $ | |||
| Volume | 5,203 | |||||

